Agreed, there is very little appetite in the market for PPHM shares based on anything less than stellar news. This may change, but it will take many quarters of strong performance from Avid and clinical Bavi success. The former looks likely, the latter not so clear.
Meanwhile, the reverse split looks inevitable. No way the share price moves up substantially under this circumstance.
GLTA, Paul